NCT01593293 - Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

266

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2015

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

PemCarbo

Pemetrexed 500mg/m2, Carboplatin AUC5 intravenously q 3 weeks for 4 cycles, followed by pemtrexed 500mg/m2 q 3 weeks for maintenance therapy

DRUG

Pem only

Pemetrexed 500mg/m2 intrvenously q 3 weeks till progression or unacceptable toxicity.

Trial Locations (1)

RECRUITING

Asan Medical Center, Seoul